Lee C Vermeulen1, Rebekah J Moles2, Jack C Collins2, Andy Gray3, Abdul Latif Sheikh4, Jacqueline Surugue5, Robert J Moss6, Marianne F Ivey7, James G Stevenson8, Yasuo Takeda9, Eurek Ranjit10, Betty Chaar2, Jonathan Penm7. 1. UW Health Center for Clinical Knowledge Management, Madison, WIUniversity of Wisconsin-Madison School of Pharmacy, Madison, WI. lc.vermeulen@hosp.wisc.edu. 2. Faculty of Pharmacy, University of Sydney, Camperdown, New South Wales, Australia. 3. School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa. 4. Pharmacy Services, Aga Khan University Hospital, Karachi, Pakistan. 5. Pharmacy Department, Centre Hospitalier Georges Renon, Niort, FranceFaculty of Pharmacy, University of Angers, Angers, France. 6. Hospital Pharmacy, MOSSysteMEDIC, Aerdenhout, Netherlands. 7. James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH. 8. Visante Inc., Ann Arbor, MICollege of Pharmacy, University of Michigan, Ann Arbor, MI. 9. Department of Clilnical Pharmacy and Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan. 10. Department of Pharmacology, Kathmandu Medical College Teaching Hospital, Kathmandu, Nepal.
Abstract
PURPOSE: The processes used to revise the 2008 Basel Statements on the future of hospital pharmacy are summarized, and the revised statements are presented. METHODS: The process for revising the Basel Statements followed an approach similar to that used during their initial development. The Hospital Pharmacy Section (HPS) of the International Pharmaceutical Federation (FIP) revised the 2008 FIP Basel Statements in four phases, including a survey of hospital pharmacists worldwide, an internal review, online forums, and a face-to-face "World Café" workshop in Bangkok, Thailand. RESULTS: The global survey on the initial Basel Statements included input from 334 respondents from 62 countries. The majority of respondents agreed that most of the initial Basel Statements were acceptable as written and did not require revision. In total, 11 statements were judged by more than 10% of respondents as needing revision or deletion. The FIP HPS executive committee used the survey results to develop 69 initial revised draft statements. After an online discussion with the international hospital pharmacy community, including individuals from 28 countries representing all six World Health Organization regions, a final set of draft statements was prepared for the live discussion involving participants from 20 countries. The final 65 revised Basel Statements were voted on and accepted. CONCLUSION: Systematic revision of the FIP Basel Statements resulted in an updated reflection of aspirational goals for the future of hospital pharmacy practice. While this revision reflects the development of new goals for hospital pharmacy practice, the core principles of the Basel Statements remain an essential foundation for the discipline.
PURPOSE: The processes used to revise the 2008 Basel Statements on the future of hospital pharmacy are summarized, and the revised statements are presented. METHODS: The process for revising the Basel Statements followed an approach similar to that used during their initial development. The Hospital Pharmacy Section (HPS) of the International Pharmaceutical Federation (FIP) revised the 2008 FIP Basel Statements in four phases, including a survey of hospital pharmacists worldwide, an internal review, online forums, and a face-to-face "World Café" workshop in Bangkok, Thailand. RESULTS: The global survey on the initial Basel Statements included input from 334 respondents from 62 countries. The majority of respondents agreed that most of the initial Basel Statements were acceptable as written and did not require revision. In total, 11 statements were judged by more than 10% of respondents as needing revision or deletion. The FIP HPS executive committee used the survey results to develop 69 initial revised draft statements. After an online discussion with the international hospital pharmacy community, including individuals from 28 countries representing all six World Health Organization regions, a final set of draft statements was prepared for the live discussion involving participants from 20 countries. The final 65 revised Basel Statements were voted on and accepted. CONCLUSION: Systematic revision of the FIP Basel Statements resulted in an updated reflection of aspirational goals for the future of hospital pharmacy practice. While this revision reflects the development of new goals for hospital pharmacy practice, the core principles of the Basel Statements remain an essential foundation for the discipline.
Authors: Hieu T Trinh; Huong T L Nguyen; Van T T Pham; Hai L Ba; Phuong T X Dong; Thao T B Cao; Hanh T H Nguyen; Jo-Anne Brien Journal: Int J Clin Pharm Date: 2018-04-07